Published in Surgery on September 01, 1975
Inflammatory Markers in Hysterectomies | NCT04184765
Inflammatory Markers in Natural Orifice Hysterectomies | NCT04221308
Burn wound infections. Clin Microbiol Rev (2006) 4.81
Laparoscopic surgery and the systemic immune response. Ann Surg (1998) 1.99
Clinical recovery from surgery correlates with single-cell immune signatures. Sci Transl Med (2014) 1.62
Inhalational anesthetics induce cell damage by disruption of intracellular calcium homeostasis with different potencies. Anesthesiology (2008) 1.52
Profile of patients with chemical injury and sensitivity. Environ Health Perspect (1997) 1.52
Association of a circulating immunosuppressive polypeptide with operative and accidental trauma. Ann Surg (1977) 1.26
Epidural analgesia improves postoperative nitrogen balance. Br Med J (1978) 1.25
Association of sepsis with an immunosuppressive polypeptide in the serum of burn patients. Ann Surg (1978) 1.15
Synergistic effect of cortisol and prostaglandin E2 on the PHA response. Relation to immunosuppression induced by trauma. Clin Exp Immunol (1976) 1.11
Intravenous hyperalimentation. Effect on delayed cutaneous hypersensitivity in cancer patients. Ann Surg (1980) 1.10
Correlation between anergy and a circulating immunosuppressive factor following major surgical trauma. Ann Surg (1979) 1.08
Host immune status in uraemia. I. Cell-mediated immune mechanisms. Clin Exp Immunol (1980) 0.98
Induction of Fas-mediated apoptosis on circulating lymphocytes by surgical stress. Ann Surg (1996) 0.96
Possible link between cyclooxygenase-inhibiting and antitumor properties of propofol. J Anesth (2011) 0.91
Effects of Corynebacterium parvum and BCG therapy on immune parameters in patients with disseminated melanoma a sequential study over 28 days. I. Changes in blood counts, serum immunoglobulins and lymphoid cell populations. Clin Exp Immunol (1979) 0.90
The significance of changes in blood lymphocyte populations following surgical operations. Clin Exp Immunol (1984) 0.90
Genotoxicity, cytotoxicity and gene expression in patients undergoing elective surgery under isoflurane anaesthesia. Mutagenesis (2011) 0.90
Effect of preoperative immunonutrition and other nutrition models on cellular immune parameters. World J Gastroenterol (2009) 0.88
Need for immunologic stimulators during immunosuppression produced by major cancer surgery. Ann Surg (1985) 0.87
Anti-tumour immunity in malignant melanoma assay by tube leucocyte adherence inhibition. Br J Cancer (1976) 0.87
Cell-mediated immunity and its role in resistance to infection. West J Med (1977) 0.85
Lymphocyte response after surgery in the neonate. Arch Dis Child (1979) 0.83
Characterization of surgical models of postoperative tumor recurrence for preclinical adjuvant therapy assessment. Am J Transl Res (2012) 0.83
Impaired production of interleukin-2 after surgery. Clin Exp Immunol (1985) 0.83
Effect of surgical trauma (gastrectomy) on cell-mediated and humoral responses in mice. Clin Exp Immunol (1985) 0.81
Up-regulation of Fas ligand (FasL) mRNA expression in peripheral blood mononuclear cells (PBMC) after major surgery. Clin Exp Immunol (1998) 0.80
Appearance of spontaneously Ig secreting B cells in human peripheral blood after surgery. Clin Exp Immunol (1986) 0.80
Clinical relevance of and risk factors for HSV-related tracheobronchitis or pneumonia: results of an outbreak investigation. Crit Care (2007) 0.79
Prospective randomized comparison of cefodizime versus cefuroxime for perioperative prophylaxis in patients undergoing coronary artery bypass grafting. Antimicrob Agents Chemother (1997) 0.79
Immunological responsiveness after transurethral resection of the prostate: general versus spinal anaesthetic. Clin Exp Immunol (1982) 0.79
Suppressor cell activity in peripheral blood in cancer patients after surgery. Clin Exp Immunol (1983) 0.78
Depression of the generation of cell-mediated cytotoxicity by suppressor cells after surgery. Clin Exp Immunol (1983) 0.78
Plasma levels of immunosuppressive mediators during cardiopulmonary bypass. Mediators Inflamm (1996) 0.77
The "in vitro skin test": a reliable and repeatable assay of immune competence in the surgical patient. Ann Surg (1981) 0.77
Spontaneous Ig secretion and DNA synthesis in lymphoblastoid B cells appearing after surgery. Clin Exp Immunol (1988) 0.77
Peri-operative modulation of cellular immunity in patients with colorectal cancer. Clin Exp Immunol (1993) 0.77
The nature of enhanced natural killer lymphocyte cytotoxicity during anesthesia and surgery in patients with benign disease and cancer. Ann Surg (1984) 0.76
CD4(+) T-lymphocytes are activated by surgical stress following colorectal resection in cancer patients. Mol Clin Oncol (2014) 0.75
Platelet lymphocyte adherence in children after surgery. Br J Exp Pathol (1987) 0.75
Depression of cellular immunity as an index of malnutrition in surgical patients. Br Med J (Clin Res Ed) (1981) 0.75
Laparotomy and laparoscopy diversely affect macrophage-associated antimicrobial activity in a murine model. BMC Immunol (2013) 0.75
Effect of beta-endorphin and cortisol on the PHA stimulated lymphoblastogenesis. Korean J Intern Med (1986) 0.75
Does intraoperative analgesia modify the immune response in surgical patients? J Anesth (1994) 0.75
The adaptive immune response to major surgery in the neonate. Pediatr Surg Int (1997) 0.75
Leukocytosis after fluid loading and induction of epidural anesthesia. J Anesth (1995) 0.75
Chemotaxis under agarose: a new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes. J Immunol (1975) 8.06
Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer (1979) 5.60
Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science (1992) 3.80
Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. J Exp Med (1992) 3.42
Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation. Medicine (Baltimore) (1980) 3.42
Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci U S A (1993) 3.24
Use of medical emergency team responses to reduce hospital cardiopulmonary arrests. Qual Saf Health Care (2004) 3.00
A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts. N Engl J Med (1989) 2.78
Surgically induced leukocytic infiltrates within the rat intestinal muscularis mediate postoperative ileus. Gastroenterology (1999) 2.75
Hepatocytes produce nitrogen oxides from L-arginine in response to inflammatory products of Kupffer cells. J Exp Med (1989) 2.49
Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc Natl Acad Sci U S A (1993) 2.46
Pancreatico-duodenal allotransplantation: experimental and clinical experience. Ann Surg (1970) 2.44
Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. N Engl J Med (1982) 2.44
The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients. Transplantation (1987) 2.40
Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation. Transplantation (1985) 2.34
Liver transplantation for type IV glycogen storage disease. N Engl J Med (1991) 2.31
An L-arginine-dependent mechanism mediates Kupffer cell inhibition of hepatocyte protein synthesis in vitro. J Exp Med (1989) 2.27
Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res (1981) 2.25
Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg (1991) 2.24
Proposed mechanisms for the translocation of intestinal bacteria. Rev Infect Dis (1988) 2.16
Modulation of nitrogen oxide synthesis in vivo: NG-monomethyl-L-arginine inhibits endotoxin-induced nitrate/nitrate biosynthesis while promoting hepatic damage. J Leukoc Biol (1990) 2.11
Isolation and sequencing of a cDNA coding for the human DF3 breast carcinoma-associated antigen. Proc Natl Acad Sci U S A (1988) 2.08
Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide. J Immunol (1991) 2.07
Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders. J Clin Microbiol (1997) 2.05
Chemiluminescence response of phagocytizing human monocytes. Infect Immun (1976) 2.01
Surgical manipulation of the gut elicits an intestinal muscularis inflammatory response resulting in postsurgical ileus. Ann Surg (1998) 2.00
Association of renal allograft rejection with virus infections. Am J Med (1974) 1.83
Pancreatic trauma: a review. Surgery (1972) 1.81
Antiserum to lymphocytes: prolonged survival of canine renal allografts. Science (1966) 1.81
Increased incidence of malignancy during chronic renal failure. Lancet (1975) 1.79
Chemiluminescence response of human leukocytes: influence of medium components on light production. Infect Immun (1977) 1.77
Family tension in the search for a kidney donor. JAMA (1971) 1.77
Alloantigen-induced activation of rat splenocytes is regulated by the oxidative metabolism of L-arginine. J Immunol (1990) 1.76
Multiple cytokines are required to induce hepatocyte nitric oxide production and inhibit total protein synthesis. Ann Surg (1990) 1.74
Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter. Proc Natl Acad Sci U S A (1996) 1.71
Recurrence of idiopathic nephrotic syndrome after renal transplantation. Lancet (1972) 1.71
Reactive nitrogen intermediates suppress the primary immunologic response to Listeria. J Immunol (1993) 1.69
Role of inducible nitric oxide synthase in postoperative intestinal smooth muscle dysfunction in rodents. Gastroenterology (2000) 1.69
Inducible cytosolic enzyme activity for the production of nitrogen oxides from L-arginine in hepatocytes. Biochem Biophys Res Commun (1990) 1.67
Monosomy 1pter. Hum Genet (1981) 1.66
Hepatocellular transplantation for metabolic deficiencies: decrease of plasms bilirubin in Gunn rats. Science (1976) 1.65
Colonoscopy in patients with a primary family history of colon cancer. Dis Colon Rectum (1990) 1.65
Comparison of FK-506 and cyclosporine regimens in pediatric renal transplantation. Pediatr Nephrol (1994) 1.55
Effect of exogenous and endogenous nitric oxide on mitochondrial respiration of rat hepatocytes. Am J Physiol (1991) 1.54
Inhibition of chemotaxis Ng-monomethyl-L-arginine: a role for cyclic GMP. Blood (1989) 1.53
Hemorrhagic shock. Curr Probl Surg (1995) 1.53
The Epstein-Barr virus in the pathogenesis of posttransplant lymphoproliferative disorders. Clinical, pathologic, and virologic correlation. Surgery (1981) 1.53
Induction of nitric oxide synthase in mouse dendritic cells by IFN-gamma, endotoxin, and interaction with allogeneic T cells: nitric oxide production is associated with dendritic cell apoptosis. J Immunol (1996) 1.53
Mechanisms of microbial synergy in polymicrobial surgical infections. Rev Infect Dis (1985) 1.51
Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells. Blood (1994) 1.49
Association of HL-A 5 and immune responsiveness in vitro to streptococcal antigens. J Exp Med (1975) 1.48
Nitric oxide and nitric oxide-generating compounds inhibit hepatocyte protein synthesis. FASEB J (1991) 1.48
Role of anaerobic flora in the translocation of aerobic and facultatively anaerobic intestinal bacteria. Infect Immun (1987) 1.46
Evidence that rat Kupffer cells stimulate and inhibit hepatocyte protein synthesis in vitro by different mechanisms. Gastroenterology (1989) 1.45
Clinical characteristics of the lethal cytomegalovirus infection following renal transplantation. Surgery (1977) 1.45
Coagulation disorders in combat casualties. I. Acute changes after wounding. II. Effects of massive transfusion. 3. Post-resuscitative changes. Ann Surg (1969) 1.44
Use of medical emergency team (MET) responses to detect medical errors. Qual Saf Health Care (2004) 1.43
Steroid diabetes in renal transplant recipients: pathogenetic factors and prognosis. Surgery (1973) 1.43
Intra-abdominal infections in pancreas transplant recipients. Ann Surg (1986) 1.42
Suppression of lipopolysaccharide-induced macrophage nitric oxide and cytokine production in vitro by a novel lipopolysaccharide antagonist. Surgery (1994) 1.42
Thigh abscess. An uncommon presentation of intraabdominal sepsis. Am J Surg (1986) 1.41
Anatomic evidence for spontaneous closure of ventricular septal defect. Circulation (1966) 1.41
Hyperglycemic nonketotic coma after liver transplantation. Arch Surg (1972) 1.40
Endogenous nitric oxide inhibits the synthesis of cyclooxygenase products and interleukin-6 by rat Kupffer cells. J Leukoc Biol (1993) 1.40
Uremic pericardial effusion. Treatment by catheter drainage and local nonabsorbable steroid administration. Nephron (1976) 1.39
Immunopathology of aging. Hum Pathol (1974) 1.39
Anti-serum to cultured human lymphoblasts: preparation, purification and immunosuppressive properties in man. Ann Surg (1969) 1.37
Isolation of Chlamydia trachomatis from the lower respiratory tract of adults. Lancet (1980) 1.37
Cure of dysgerminoma with widespread metastases appearing after renal transplantation. N Engl J Med (1970) 1.36
Cyclosporin A in renal transplantation: a prospective randomized trial. Surgery (1982) 1.36
Role of resident macrophages, peripheral neutrophils, and translymphatic absorption in bacterial clearance from the peritoneal cavity. Infect Immun (1985) 1.35
Cytomegalovirus: Clinical virological correlations in renal transplant recipients. Ann Surg (1974) 1.34
Full trisomy 7 and Potter syndrome. Hum Genet (1980) 1.34
Herpes simplex virus hepatitis after solid organ transplantation in adults. J Infect Dis (1991) 1.33
Immunotherapy of cancer: immunospecific rejection of tumors in recipients of neuraminidase-treated tumor cells plus BCG. Science (1971) 1.33
A central role for IL-1 beta in the in vitro and in vivo regulation of hepatic inducible nitric oxide synthase. IL-1 beta induces hepatic nitric oxide synthesis. J Immunol (1995) 1.33
Pathologic anatomy of the lungs following shock and trauma. J Trauma (1968) 1.33
Chemotactic deactivation of human neutrophils: evidence for nonspecific and specific components. Infect Immun (1978) 1.33
Effect of neuraminidase on the stimulatory capacity of cells in human mixed lymphocyte cultures. Clin Exp Immunol (1971) 1.32
Acquired immunologic deficiencies after trauma and surgical procedures. Surg Gynecol Obstet (1974) 1.30
Immunogenicity and antigenicity of lymphoid cells treated with neuraminidase. Nat New Biol (1971) 1.29
Murine chromosomal regions correlated with longevity. Genetics (1988) 1.29
Prevention of urological complications after kidney transplantation. Ann Surg (1971) 1.29
Renal transplantation in high-risk patients. Arch Surg (1971) 1.28
Secondary bacterial peritonitis: the biologic basis of treatment. Curr Probl Surg (1979) 1.28
Chemotactic deactivation of human neutrophils: possible relationship to stimulation of oxidative metabolism. Infect Immun (1979) 1.27
Seven years' experience with antilymphoblast globulin for renal transplantation from cadaver donors. Ann Surg (1976) 1.26
Antibiotic trials in intra-abdominal infections. A critical evaluation of study design and outcome reporting. Ann Surg (1984) 1.26
Cellular non-heme iron content is a determinant of nitric oxide-mediated apoptosis, necrosis, and caspase inhibition. J Biol Chem (2000) 1.25
Renal transplantation in children ages 1 to 5 years. Pediatrics (1978) 1.25
Inhibition of nitric oxide synthesis during endotoxemia promotes intrahepatic thrombosis and an oxygen radical-mediated hepatic injury. J Leukoc Biol (1992) 1.25
Intestinal bacteria translocate into experimental intra-abdominal abscesses. Arch Surg (1986) 1.24
The clinical use of antilymphocyte globulin. N Engl J Med (1971) 1.24
Incidence of trimethoprim-sulfamethoxazole-resistant enterobacteriaceae among transplant recipients. J Infect Dis (1984) 1.24
Fibrin in peritonitis. I. Beneficial and adverse effects of fibrin in experimental E. coli peritonitis. Surgery (1980) 1.24
EPR detection of heme and nonheme iron-containing protein nitrosylation by nitric oxide during rejection of rat heart allograft. J Biol Chem (1992) 1.24
Biphasic response to gut manipulation and temporal correlation of cellular infiltrates and muscle dysfunction in rat. Surgery (1999) 1.24
Role of virus infections in immunosuppressed renal transplant patients. Transplant Proc (1973) 1.23
The role of Candida in intraperitoneal infections. Surgery (1980) 1.22